About our Premium Reports
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
No longer experiencing double-digit economic growth, China’s economy has settled into a respectable but lower growth rate range between 6 to 7% annually. As the central planners prescribed, the economy is now shifting from quantity growth to higher quality growth. The increasing willingness to embrace foreign technology, on their terms, combined with the lower bureaucratic barriers, is creating significant opportunities for investment. China’s government expect integrated digital solutions to improve service levels, enhance trust with patients and facilitate communication among professionals for diagnosis and consultation.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com